Towards More Shared Decision Making in Dermatology: Develop-ment of Evidence-based Decision Cards for Psoriasis and Atopic Eczema Treatments
| Autor: | Ronald A Tupker, Hans Blaauwbroek, Phyllis I. Spuls, Renske Kranenburg, Josine S van der Kraan, Tessa Geltink, Anne Bijlsma, F.M. Vermeulen, Dirk J van der Veen, Gayle E. van der Kraaij, Kristie Venhorst, Francine Das |
|---|---|
| Přispěvatelé: | Graduate School, AII - Inflammatory diseases, APH - Methodology, APH - Quality of Care, Dermatology, APH - Personalized Medicine |
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
Evidence-based practice Decision Making Dermatology Systemic therapy Decision card Dermatitis Atopic Clinical expertise 030207 dermatology & venereal diseases 03 medical and health sciences 0302 clinical medicine Psoriasis medicine lcsh:Dermatology Humans Summary of Product Characteristics Shared decision making Physician-Patient Relations business.industry Frequently asked questions Treatment options General Medicine lcsh:RL1-803 medicine.disease Encounter decision aids Atopic eczema Apremilast Patient Participation business Decision Making Shared medicine.drug |
| Zdroj: | Acta dermato-venereologica, 100(19):adv00337, 1-8. Society for the Publication of Acta Dermato-Venereologica Acta Dermato-Venereologica, Vol 100, Iss 19, p adv00337 (2020) |
| ISSN: | 0001-5555 |
| Popis: | In shared decision making (SDM) patients and physi-cians make treatment decisions together based on the best available evidence and the values and preferences of patients. SDM is very suitable for use in dermatological practice, but is infrequently applied by dermatologists. To support the application of SDM in dermatology we developed Decision Cards: 1-page overviews of possible treatment options, for use during a patient-physician consultation. Decision Cards provide answers to patients' most frequently asked questions, based on (inter)national guidelines, Summary of Product Characteristics, relevant literature, and clinical expertise. Three evidence-based Decision Cards were developed: 1 for biologicals or apremilast in psoriasis, and 2 for atopic eczema (1 for topical, photo- or systemic therapy, and 1 for systemic therapy only). More cards for psoriasis are currently in development. Patients, dermatologists and researchers collaborated in the development of the Decision Cards. This paper shares the framework used for the development of the Decision Cards, in order to support others in the development process. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|